Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
07/2012
07/24/2012CA2458146C Use of milk serum apoproteins in the prophylaxis or treatment of microbial or viral infection
07/24/2012CA2394623C Process for preparing and isolating 9-deoxo-9(z)-hydroxyiminoerythromycin a
07/24/2012CA2342289C Treatment of cervical cancer
07/19/2012WO2012097273A1 Solid forms of gyrase inhibitor (r)-1-ethyl-3-[6-fluoro-5-[2-(1-hydroxy-1-methyl-ethyl) pyrimidin-5-yl]-7-(tetrahydrofuran-2-yl)-1h-benzimidazol-2-yl]urea
07/19/2012WO2012097269A1 Pyrimidine gyrase and topoisomerase iv inhibitors
07/19/2012WO2012097223A2 Oligosaccharide conjugates for targeting bacteria and uses related thereto
07/19/2012WO2012097185A2 Omv vaccine against burkholderia infections
07/19/2012WO2012097123A2 New uses of cyclophilin inhibitors
07/19/2012WO2012096926A2 Method for delivering agents into cells using bacterial toxins
07/19/2012WO2012096596A1 Antiviral agent
07/19/2012WO2012096595A1 Palladium-copper catalysts for the homogeneous selective oxidation of thiol groups
07/19/2012WO2012095853A1 Modified release formulations comprising sip receptor modulators
07/19/2012WO2012095792A1 Sugar derivatives having tensioactive and antimicrobial activity
07/19/2012WO2012095705A1 Pharmaceutically acceptable salts of novel betulinic acid derivatives
07/19/2012WO2012095388A2 Compounds for treatment of feline leukemia in felidae
07/19/2012WO2012094838A1 Use and pharmaceutical composition of lignosulfonate
07/19/2012WO2012068998A3 Triamcinolone acetonide ophthalmic preparation and preparation method thereof
07/19/2012WO2012067866A3 Multivalent vaccine for filariasis
07/19/2012WO2012067483A3 Newcastle disease virus and the use thereof as a vaccine
07/19/2012WO2012058492A3 Viral vaccine and process for preparing the same
07/19/2012WO2012051492A3 Compounds and methods for inhibiting hiv latency
07/19/2012WO2012035489A9 Use of derivatives of pentaphyrine as antimicrobial and desinfectant agents
07/19/2012WO2012034077A3 Compositions and methods related to attenuated staphylococcal strains
07/19/2012WO2012027411A3 Compositions and uses of materials with high antimicrobial activity and low toxicity
07/19/2012WO2012021786A3 Anti-hemagglutinin antibody compositions and methods of use thereof
07/19/2012WO2012021735A3 Pharmaceutical products from fungal strains
07/19/2012WO2011163628A3 Dengue virus (dv) polypeptide sequences, t cell epitopes and methods and uses thereof
07/19/2012WO2011160078A3 Use of camelid-derived variable heavy chain variable regions targeting cd18 and icam-1 as a microbicide to prevent hiv-1 transmission
07/19/2012WO2011038473A8 Method, kit, plasmid and composition for inducing an immune response to dengue virus, on the basis of dna and chimeric virus vaccines
07/19/2012US20120184626 Germicidal topical compositions
07/19/2012US20120184606 Neuraminidase inhibitor compounds, compositions and methods for the use thereof in anti-viral treatments
07/19/2012US20120184601 Antiviral oligonucleotides
07/19/2012US20120184600 Inhibition of Glycerol-3-Phosphate Acyltransferase (GPAT) and Associated Enzymes for Treatment of Viral Infections
07/19/2012US20120184599 Use of MicroRNA for Treating Diseases Associated with a Dysfunction of the Cilia in Multiciliated Epithelial Cells
07/19/2012US20120184583 Modulators of atp-binding cassette transporters
07/19/2012US20120184574 Indole derivatives and methods for antiviral treatment
07/19/2012US20120184564 Solid forms of gyrase inhibitor (r)-1-ethyl-3-[6-fluoro-5-[2-(1-hydroxy-1-methyl-ethyl)pyrimidin-5-yl]-7-(tetrahydrofuran-2-yl)-1h-benzimidazol-2-yl]urea
07/19/2012US20120184557 Pyrazolo[1,5-a]-1,3,5-triazine derivatives, preparation thereof, and therapeutic use thereof
07/19/2012US20120184519 Compositions and Methods for Preventing or Treating Influenza Virus Infection
07/19/2012US20120184512 Gyrase and topoisomerase iv inhibitors
07/19/2012US20120184507 Leaven-based mixture
07/19/2012US20120184503 Nutritional compositions comprising human milk oligosaccharides and nucleotides and uses thereof for treating and/or preventing enteric viral infection
07/19/2012US20120184502 Optimised formulation of tobramycin for aerosolization
07/19/2012US20120184501 Antibacterial aminoglycoside analogs
07/19/2012US20120184497 Dalbavancin compositions for treatment of bacterial infections
07/19/2012US20120184496 Ophthalmic pharmaceutical compositions of dp2 receptor antagonists
07/19/2012US20120184493 Dermal formulations of dp2 receptor antagonists
07/19/2012US20120184482 Novel Ubiquitin-Isopeptide Probes
07/19/2012US20120183626 Antiseptic ointment comprising bentonite intercalated with silver, copper or zinc for external application
07/19/2012US20120183597 Method of inducing neutralizing antibodies to human immunodeficiency virus
07/19/2012US20120183593 Hydrogels used to deliver medicaments to the eye for the treatment of posterior segment diseases
07/19/2012US20120183588 High load dispersions
07/19/2012US20120183585 Gel based wound dressing and a method of synthesizing the same
07/19/2012US20120183583 Medical Device With Intrapore Films
07/19/2012US20120183579 Compounds for inflammation and immune-related uses
07/19/2012US20120183578 Polyethylene glycol-based dendrons
07/19/2012US20120183577 Compositions useful as inhibitors of protein kinases
07/19/2012US20120183576 Modified gram-negative bacteria for use as vaccines
07/19/2012US20120183575 Exosome based treatment of cancer
07/19/2012US20120183574 Modified vaccinia virus ankara for the vaccnation of neonates
07/19/2012US20120183573 Intracellular viral vector delivery method employing iron ion/viral vector composite
07/19/2012US20120183570 Antigen compositions and methods of inhibiting campylobacter jejuni bacterial infection and uses of the antigen compositions
07/19/2012US20120183569 Recombinant feline leukemia virus vaccine containing optimized feline leukemia virus envelope gene
07/19/2012US20120183564 Inhibition of endosomal toll-like receptor activation
07/19/2012US20120183563 Iminothiadiazine dioxide compounds as bace inhibitors, compositions and their use
07/19/2012US20120183558 Antibody molecules which bind il-17a and il-17f
07/19/2012US20120183557 Hiv tat-cd4 hybrid molecules and methods of use thereof
07/19/2012US20120183550 Therapeutic Using a Bispecific Antibody
07/19/2012US20120183533 Mimotopes of hiv env
07/19/2012US20120183532 Compounds stimulating undesirable cellular adhesion and applications thereof
07/19/2012US20120183508 Gamma secretase inhibitor for treatment of herpesvirus infection
07/19/2012US20120183498 Compounds, compositions and methods for treating or preventing pneumovirus infection and associated diseases
07/19/2012US20120183497 Method of Determining Response to Treatment with Immunomodulatory Composition
07/19/2012US20120183496 Inhibitors of hepatitis c virus polymerase
07/19/2012US20120181201 Topical Formulation Containing a Tetracycline and a Method of Treating Skin Infections Using the Same
07/19/2012CA2824800A1 Oligosaccharide conjugates for targeting bacteria and uses related thereto
07/19/2012CA2824516A1 Pyrimidine gyrase and topoisomerase iv inhibitors
07/19/2012CA2824438A1 Use of toll-like receptor agonist for treating cancer
07/19/2012CA2824403A1 Solid forms of gyrase inhibitor (r)-1-ethyl-3-[6-fluoro-5-[2-(1-hydroxy-1-methyl-ethyl)pyrimidin-5-yl]-7-(tetrahydrofuran-2-yl)-1h-benzimidazol-2-yl]urea
07/19/2012CA2824389A1 Antibodies directed against influenza
07/19/2012CA2824154A1 Method for delivering agents into cells using bacterial toxins
07/18/2012EP2476752A1 Process for production of natural killer cells
07/18/2012EP2476701A1 Antimicrobial agents based on hemin derivatives
07/18/2012EP2476690A1 Compounds and pharmaceutical compositions for the treatment of viral infections
07/18/2012EP2476683A2 Novel tetra-aza macrocyclic compound, method for preparing same, and use thereof
07/18/2012EP2476440A1 Therapeutic compositions for the treatment of hpv-induced diseases
07/18/2012EP2476434A1 Immunogenic composition
07/18/2012EP2476433A1 Immunogenic composition
07/18/2012EP2476432A1 Compositions that include hemagglutinin, methods of making and methods of use thereof
07/18/2012EP2476420A1 Pharmaceutical composition having antimicrobial and fast-healing activity for external administration, process for preparing same
07/18/2012EP2476419A1 Pharmaceutical composition having antimicrobial and anti-inflammatory activity for parenteral administration, process for preparing same
07/18/2012EP2475666A2 Gyrase inhibitors
07/18/2012EP2475657A1 Inhibitors of flaviviridae viruses
07/18/2012EP2475384A1 New vaccine formulations comprising saponin-containing adjuvants
07/18/2012EP2475377A2 Novel bacteriophage and antibacterial composition comprising the same
07/18/2012EP2475365A1 Compositions of n-benzyl-3-(4-chlorophenyl)-2-[methyl-[2-oxo-2-(3,4,5-trimethoxyphenyl) acetyl]amino]-n-[3-(4-pyri(dyl)-1-[2-[4-pyridyl)ethyl]propyl]propanamide and uses thereof
07/18/2012EP2475253A1 Methods for treating malaria, tuberculosis and mac diseases
07/18/2012EP1959990B1 PQS and its conjugates as adjuvants and their uses in pharmaceutical compositions
07/18/2012EP1470148B1 Double-stranded oligonucleotides
07/18/2012EP1437961B1 Methods of suppressing microglial activation
1 ... 262 263 264 265 266 267 268 269 270 271 272 273 274 275 276 277 278 279 280 281 282 ... 1798